Please take a moment to get acquainted with our diamond speakers of the event!
💎 Lauri Kuronen, CEO, VEIL.AI Denmark ApS
Lauri Kuronen has over 13 years of experience in early-stage Health, Life Science and MedTech companies and helping them to develop their business. He is the CEO of VEIL.AI Denmark ApS, Helsinki and Copenhagen based company which is specialized in health data anonymization services and synthetic data.
💎 Hannu Toivonen, Professor of Computer Science, University of Helsinki
Professor Hannu Toivonen is a leading expert in data science and computational creativity. He has researched various topics within AI since 1990, both in academia and industry. He has published over 200 scientific articles and has been cited 27000 times. He is the author of the popular non-fiction book “Mitä tekoäly on?” (What is AI?) and known for his ability to explain AI in simple terms.
💎 Joona Pylkäs, Head of Data and AI, Tietoevry Care
Joona Pylkäs is a seasoned technology executive who enjoys working in the intersection of technology, product and business. Joona has over 20 years of experience from working with Nordic healthcare IT, data and AI solutions. He currently leads Tietoevry Care’s Data and Analytics business.
💎 Nasim Farrokhnia, MD, PhD, MBA, Healthcare Executive, Microsoft Global Healthcare and Life Sciences Team
💎 Markus Kalliola, Project Director, Sitra
💎 Sammeli Liikkanen, Director, Digital Medicine at Orion Oyj Corporation
Sammeli Liikkanen (PhD, eMBA) is the Director of Digital Medicine at Orion Pharma’s R&D. While transforming the ideation, innovation, and research processes of novel medicines internally with the data and AI, he also acts as the leader of Orion’s four years long research ecosystem project (orion.fi/en/ecosystem). Sammeli also advises several other startup and biotech companies in their digitally flavored objectives and issues
💎 Mikko Kytö, Development Manager at Helsinki University Central Hospital, IT management
💎 Tarja Laitinen, Director of Research
Dr Tarja Laitinen has been the Director of Research at Tampere University Hospital 2018-2024. Before that she has hold several positions in the academia and biotech industry: Chief Physician and Professor in Respiratory Diseases at Turku University Hospital, and the CSO and co-founder of the BioHealthCareInformatics Company Geneos Ltd. She has actively participated in the development of Biobank Research and Clinical Informatics in Finland for several years.
💎 Erkki Soini, CEO at ESiOR, Chairman at Kuopio Health
Erkki Soini is the CEO of ESiOR Oy and the chairman of Kuopio Health's board of directors and the health and well-being data working group. Erkki is an internationally and nationally awarded health economics and effectiveness research professional who has been recognized five times. He specializes in evaluating and predicting the efficiency and effectiveness of pharmaceuticals, health technology, and healthcare and social care processes. For example, he has served as the invited chairman of the scientific evaluation board of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Europe for two terms. Erkki has also been elected as a permanent expert and author in the TEHDAS project, which aims at the European health data space (EHDS). Additionally, he has been an invited expert in the Käypä Hoito working group and has participated in the steering and expert groups of several effectiveness research projects, as well as serving on the boards of various organizations.
💎 Rafael Rodrigo, Key Account Manager, Swedish Pharma Insights
💎 Jussi Leinonen, Strategic Project Lead, Bayer Oy
Jussi Leinonen is a seasoned professional with a diverse background in biomedical research & data science. Currently serving as the Strategic Project Lead at Bayer R&D, he has been with Bayer for over six years, focusing on driving innovation in clinical trials since 2020. His expertise lies in strategic partnerships & global drug development with a special interest in precision medicine & regenerative biology. He is an MD, whose educational background includes a Ph.D. in Stem Cell Biology & Genetics from The Hebrew University and an Executive MBA from the Quantic School of Business and Technology
